Biogen CEO: Want to stop inversions? Reform tax code

Wednesday, 23 Jul 2014 | 11:45 AM ET

CNBC's Meg Tirrell speaks to Dr. George Scangos, Biogen Idec CEO, about the company's Q2 earnings surge, drug pipeline, and America's tax code. Scangos says we need a corporate tax rate that is competitive with rest of the world and a territorial tax system.